Stock Analysis of NeuBase Therapeutics Inc (NBSE) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code NBSE
Close 0.378
Change -0.0125 / 3.20 %
Volume 94885.00
Vol Change 35909.00 / 60.89 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Mild Growth
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of NeuBase Therapeutics Inc
PE (TTM)

-0.0233

Very Poor
Price / Book

0.0209

Excellent
Price / Sales

0

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

1418.10 K

Enterprise Value

-21073.86 K

ROA (TTM)

-56.60

Very Poor
ROE (TTM)

-89.59

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

32.93 %

-33776.45 K
Debt to Equity

0.0285

Excellent
Altman Z Score

-6.97

Very Poor
Quick Ratio

5.95

Very Good
Cash Ratio

5.56

Very Good


Highs/Lows of NeuBase Therapeutics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.405 6.67 % 0.513 % 0.42990.3607-May-2406-May-24
Two Week0.4396 14.01 % 0.486 % 0.43980.3630-Apr-2406-May-24
One Month0.4012 5.78 % 4.80 % 0.46530.3615-Apr-2406-May-24
Three Month0.68 44.41 % 3.56 % 1.150.3620-Mar-2406-May-24
Six Months0.6744 43.95 % 15.54 % 1.510.3630-Nov-2306-May-24
One year3.798 90.05 % 26.26 % 4.70.3622-May-2306-May-24
Two year19.552 98.07 % 27.72 % 10.20.3626-Sep-2206-May-24
Five year51.4 99.26 % 91.77 % 8.20.120613-Feb-2325-Apr-23
Ten year2748.0 99.99 % 174.36 % 4924.00.120605-Mar-1525-Apr-23


Technical View of NeuBase Therapeutics Inc
RSI

30.84

Neutral
MACD

-0.0444

Bullish
ADX

23.02

Bearish
Super Trend

0.482

Mild Bearish
Williams %R

-80.00

Neutral
CCI

-204.35

Mild Bearish


EMA 5

0.394

Strong Bearish
EMA 15

0.414

Strong Bearish
EMA 50

0.531

Strong Bearish
EMA 100

0.661

Mild Bearish
SMA 100

0.649

Mild Bearish
SMA 200

0.762

Strong Bearish
SMA 5 / 20

0.397 / 0.415

Strong Bearish
SMA 15 / 50

0.413 / 0.603

Mild Bearish
SMA 50 / 200

0.603 / 0.762

Mild Bearish




Charts of NeuBase Therapeutics Inc


Returns of NeuBase Therapeutics Inc with Peers
Period / StockNBSELSDIINFINMRD
1 Week-6.67%-5.05%-23.81%-3.00%
1 Mth-5.78%-0.697%-80.15%-19.17%
3 Mth-44.41%-51.70%-92.38%-36.27%
6mth-43.95%-58.21%-91.58%-78.05%
1 Year-90.05%-92.56%-98.66%-90.28%
2 Year-98.07%--99.52%-98.25%
5 Years-99.26%--99.41%-99.46%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of NeuBase Therapeutics Inc with Peers
Ratio / StockNBSELSDIINFINMRD
PE-0.0233-0.107-9.00-0.162
P/B0.02090.739-18.63-0.101
ROA-56.60-164.89-96.89-74.55
ROE-89.59-689.7000
Debt To Equity0.02850.085-0.0311-1.70
Revenue0
% 		7048.00
% 		2593.00 K
39.56 % 		-1476.39 K
392.99 %
Net Income-33776.45 K
32.93 % 		-8988.46 K
53.49 % 		-43256.00 K
4.43 % 		-25104.74 K
80.78 %


Technicals of NeuBase Therapeutics Inc with Peers
Technical / StockNBSELSDIINFINMRD-
ADX23.0227.8539.5828.15
CMF-0.100-0.134-0.324-0.337
MFI13.6995.572.0364.35
RSI30.8443.6726.2348.59
MACD Abv SignalTrueFalseFalseTrue
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : NeuBase Therapeutics Inc

Address : 350 Technology Drive, Pittsburgh, PA, United States, 15219
Tel : 412 763 3350
URL : https://www.neubasetherapeutics.com
Code : NBSE, ISIN : US64132K1025, Exchange : NASDAQ, Country : USA
Fiscal Year End : September
IPO date : 01_May_2007
Employee Count : 37

NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.


Note : All Data Generated at the End of Trading Hours (EOD Data)